tradingkey.logo
tradingkey.logo
Suchen

Allurion Technologies Inc

ALUR
Zur Watchlist hinzufügen
0.671USD
0.0000.00%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
5.50MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Allurion Technologies Inc Unternehmen

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.

Allurion Technologies Inc Informationen

BörsenkürzelALUR
Name des UnternehmensAllurion Technologies Inc
IPO-datumMar 29, 2021
CEOGaur (Shantanu)
Anzahl der mitarbeiter134
WertpapierartOrdinary Share
GeschäftsjahresendeMar 29
Addresse11 Huron Dr Ste 200
StadtNATICK
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl01760
Telefon15086474000
Websitehttps://www.allurion.com/en
BörsenkürzelALUR
IPO-datumMar 29, 2021
CEOGaur (Shantanu)

Führungskräfte von Allurion Technologies Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
4.13K
--
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
81.00
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
Mr. Keith Johns
Mr. Keith Johns
Independent Director
Independent Director
--
--
Mr. R. Jason Richey
Mr. R. Jason Richey
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
4.13K
--
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
81.00
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Allurion Technologies Inc?

Die fünf größten Anteilseigner von Allurion Technologies Inc sind: Dr. Shantanu Gaur, M.D.

Wie viele Institutionen halten Anteile an Allurion Technologies Inc (ALUR)?

Mit Stand vom 2026Q1 halten 70 Institutionen Anteile an Allurion Technologies Inc, mit einem Gesamtmarktwert von etwa 6.90M, was 46.01% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 132951.00 gestiegen.